P&G/Teva Joint Venture Lays Foundation For Switches, Product Launches
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble and Teva Pharmaceutical Industries combine their consumer businesses in a joint venture that creates a leading platform for Rx-to-OTC switches and new consumer health products.
You may also be interested in...
People In Brief
Bristol-Myers exec to head Teva; GSK’s Witty now Sir Andrew; ISPE names Berg president; more People In Brief.
People In Brief
Bristol-Myers exec to head Teva; GSK’s Witty now Sir Andrew; ISPE names Berg president; more People In Brief.